MYCML
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Nov 2022)
What this means for you
This application is over — abandoned 21 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87806776
- Mark type
- Stylized text
- Filed
- 22 Feb 2018
- Published for opposition
- 20 Aug 2019
- Abandoned
- 21 Nov 2022
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
- Class 005 — Pharmaceuticals: Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
- Class 042 — Scientific and technological services: DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
Owner
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 21 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Apr 2022 — SOU EXTENSION 5 GRANTED
- 06 Apr 2022 — SOU EXTENSION 5 FILED
- 12 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 13 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Oct 2021 — SOU EXTENSION 4 GRANTED
- 11 Oct 2021 — SOU EXTENSION 4 FILED
- 11 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2021 — SOU EXTENSION 3 GRANTED
- 08 Apr 2021 — SOU EXTENSION 3 FILED
- 08 Apr 2021 — SOU TEAS EXTENSION RECEIVED